We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKEPP
4751
DELISTED
Blueknight Energy Partners L.P., L.L.C. Series A Preferred Units
BKEPP
$8K ﹤0.01%
922
+761
+473% +$6.52K
UBOH
4752
DELISTED
United Bancshares Inc/OH
UBOH
$8K ﹤0.01%
+264
New +$8.34K
MTL
4753
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$8K ﹤0.01%
3,534
– –
ACXP icon
4754
Acurx Pharmaceuticals
ACXP
$6.36M
$7K ﹤0.01%
88
-78
-47% -$5.25K
ADAG
4755
Adagene
ADAG
$246M
$7K ﹤0.01%
3,627
-1,365
-27% -$4.13K
AHT
4756
Ashford Hospitality Trust
AHT
$20.2M
$7K ﹤0.01%
123
+22
+22% +$1.48K
AIRI icon
4757
Air Industries Group
AIRI
$12.2M
$7K ﹤0.01%
960
+216
+29% +$1.59K
AMST icon
4758
Amesite
AMST
$7.01M
$7K ﹤0.01%
1,263
+642
+103% +$4.45K
ASM
4759
Avino Silver & Gold Mines
ASM
$1.21B
$7K ﹤0.01%
13,185
+12,696
+2,596% +$9.24K
ASNS
4760
DELISTED
ACTELIS NETWORKS INC
ASNS
$7K ﹤0.01%
+43
New +$6.84K
ATLC icon
4761
Atlanticus Holdings
ATLC
$1.47B
$7K ﹤0.01%
193
-39
-17% -$1.56K
AUUD
4762
Auddia
AUUD
$5.47M
$7K ﹤0.01%
+2
New +$9.53K
AVD icon
4763
American Vanguard Corp
AVD
$62.8M
$7K ﹤0.01%
292
-49
-14% -$1.1K
BRAG
4764
Bragg Gaming Group
BRAG
$46.2M
$7K ﹤0.01%
+1,618
New +$8.67K
BRTX icon
4765
BioRestorative Therapies
BRTX
$5.61M
$7K ﹤0.01%
2,365
+1,435
+154% +$6.08K
CARE icon
4766
Carter Bankshares
CARE
$757M
$7K ﹤0.01%
494
+161
+48% +$2.47K
CELZ icon
4767
Creative Medical Technology
CELZ
$8.17M
$7K ﹤0.01%
955
+251
+36% +$4.05K
CIO
4768
DELISTED
City Office REIT
CIO
$7K ﹤0.01%
508
-15
-3% -$212
CKPT
4769
DELISTED
Checkpoint Therapeutics
CKPT
$7K ﹤0.01%
651
+365
+128% +$4.78K
CLGN icon
4770
CollPlant Biotechnologies
CLGN
$6.02M
$7K ﹤0.01%
+892
New +$8.19K
CLOU icon
4771
Global X Cloud Computing ETF
CLOU
$281M
$7K ﹤0.01%
+416
New +$7.73K
CLRB icon
4772
Cellectar Biosciences
CLRB
$19.8M
$7K ﹤0.01%
55
+27
+96% +$3.86K
CLRO icon
4773
ClearOne Inc
CLRO
$15.2M
$7K ﹤0.01%
925
+297
+47% +$2.96K
CNTA
4774
DELISTED
Centessa Pharmaceuticals
CNTA
$7K ﹤0.01%
1,477
+232
+19% +$1.48K
CODA icon
4775
Coda Octopus Group
CODA
$115M
$7K ﹤0.01%
1,564
+21
+1% +$115
189 190
191
192 193

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.